Maravai Lifesciences Holdings's market cap is currently $997.48M. The company's EPS TTM is $-1.648; its P/E ratio is ―; Maravai Lifesciences Holdings is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 288.94M	$ 883.00M	$ 799.24M	$ 284.10M	$ 143.14M
Gross Profit	$ 140.20M	$ 714.04M	$ 658.68M	$ 204.45M	$ 76.29M
Operating Income	$ -31.65M	$ 574.22M	$ 554.64M	$ 67.60M	$ 23.99M
EBITDA	$ 712.41M	$ 609.99M	$ 585.78M	$ 138.27M	$ 48.19M
Net Income	$ -119.03M	$ 490.66M	$ 469.25M	$ 76.89M	$ -5.20M
Balance Sheet
Cash & Short-Term Investments	$ 574.96M	$ 632.14M	$ 551.27M	$ 236.18M	$ 24.70M
Total Assets	$ 1.49B	$ 2.28B	$ 1.92B	$ 1.27B	$ 577.80M
Total Debt	$ 610.97M	$ 585.26M	$ 534.31M	$ 590.78M	$ 390.20M
Net Debt	$ 36.01M	$ -46.88M	$ -16.96M	$ 354.60M	$ 365.50M
Total Liabilities	$ 697.57M	$ 1.38B	$ 1.37B	$ 1.12B	$ 433.17M
Stockholders' Equity	$ 416.75M	$ 545.22M	$ 315.50M	$ 88.51M	$ 141.40M
Cash Flow
Free Cash Flow	$ 60.67M	$ 518.89M	$ 353.72M	$ 126.78M	$ 6.97M
Operating Cash Flow	$ 126.22M	$ 535.98M	$ 368.57M	$ 152.19M	$ 24.11M
Investing Cash Flow	$ -122.31M	$ -267.61M	$ 105.66M	$ 6.07M	$ -17.15M
Financing Cash Flow	$ -61.09M	$ -187.50M	$ -159.05M	$ 53.21M	$ -4.17M

Currency in USD

Maravai Lifesciences Holdings Earnings and Revenue History

Income Statement >

Maravai Lifesciences Holdings Debt to Assets

Balance Sheet >

Maravai Lifesciences Holdings Cash Flow

Cash Flow >

Maravai Lifesciences Holdings Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing